ERCC1 and esophageal squamous cell carcinoma: In a review that evaluated the biomarkers for predicting the response and/or prognosis of ESCC patients treated with neoadjuvant chemoradiation therapy, expression levels of ERCC1 were considered to be an independent risk factor for poor outcomes (11).